GLYTHERIX LTD.
GlyTherix Ltd is an Australian immuno-oncology company specializing in therapeutics for solid tumors, including prostate, bladder and pancreas. GlyTherix is developing Miltuximab® for the targeted treatment of a number of cancers. At the core of the technology is a protein known as Glypican-1 (GPC-1). GPC-1 occurs in many solid tumors such as prostate, bladder, pancreatic, glioblastoma, esophageal, ovarian and brain cancers. It is not present in healthy tissue.
GLYTHERIX LTD.
Industry:
Therapeutics
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.glytherix.com
Status:
Active
Contact:
(02) 9850 4000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Official Site Inspections
http://www.glytherix.com
- Host name: 655191.cloudwaysapps.com
- IP address: 128.199.234.225
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62
